Organization: Health Canada
Year: 2024
Month: January
Request Number: A-2022-000909
Request Summary: The most current status of the Abbreviated New Drug Submission (ANDS) seeking approval of a generic degarelix acetate product (Control No. 245431), which last received a Screening Acceptance Letter from Health Canada on March 7, 2022 for the sponsor’s Response to a Notice of Non-Compliance, dated August 23, 2021.
Disposition: Disclosed in part
Number of pages: 9